🇺🇸 FDA
Pipeline program

Testosterone Topical Gel, 1.62% Metered Pump

AL1401

Phase 3 small_molecule completed

Quick answer

Testosterone Topical Gel, 1.62% Metered Pump for Primary Hypogonadism is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amneal Pharmaceuticals
Indication
Primary Hypogonadism
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials